ImmunologybioRxiv
Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product development
M. Z. Ballmann, S. Raus, R. Engelhart…·A. H. Baker
This paper describes the development of a novel adenoviral vector, HAdV-20-42-42, which shows promise for gene therapy and vaccination due to its low seroprevalence and effective transduction capabilities.